AC

Agati Capital

Description

Agati Capital is an investment firm.

Investor Profile

Agati Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Australia.
  • Strong thematic focus on Biotechnology, Health Care, Wellness.

Stage Focus

  • Series B (100%)

Country Focus

  • Australia (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Agati Capital frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Uniseed
Oceania, Queensland, Australia, Brisbane
Co-Investments: 1
Breakthrough Victoria
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
UniSuper
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1

What are some of recent deals done by Agati Capital?

Aravax

Melbourne, Victoria, Australia

Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.

BiotechnologyHealth CareWellness
Series BJan 23, 2024
Amount Raised: $22,200,000